Literature DB >> 2084287

Current techniques for infrainguinal arterial reconstruction.

A Whittemore1.   

Abstract

Infrainguinal reconstruction for peripheral vascular occlusive disease comprises an increasingly complex array of interventions which provide unparalleled options for the salvage of threatened limbs. Conventional autogenous saphenous vein bypass remains the most durable revascularization with anticipated graft patency rates approaching 80 percent after five years and excellent long term limb salvage. These excellent results are equally applicable to vein grafts carried to infrapopliteal and even inframalleolar levels, possibly reflecting increased utilization of the in situ method. Although 20 per cent of grafts fail within five years, secondary intervention results in sustained limb salvage in the majority of patients. In the absence of autogenous vein, however, prosthetic material performs poorly such that new interventions consisting of percutaneous transluminal angioplasty, rotary atherectomy devices and laser systems are under aggressive development. Although initial results with these devices are encouraging, long term patency rates remain poor largely due to restenosis. Further progress seems to depend primarily on an increased understanding of the natural healing response of the injured artery.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2084287     DOI: 10.1007/BF02471025

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  73 in total

1.  Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. Report of a prospective randomized trial in a selected group of patients.

Authors:  S E Wilson; G L Wolf; A P Cross
Journal:  J Vasc Surg       Date:  1989-01       Impact factor: 4.268

2.  Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.

Authors:  M F Meyerovitz; S Z Goldhaber; K Reagan; J F Polak; K Kandarpa; C J Grassi; B C Donovan; M A Bettmann; D P Harrington
Journal:  Radiology       Date:  1990-04       Impact factor: 11.105

3.  Long-term results of 474 arterial reconstructions for severely ischemic limbs: a fourteen year follow-up.

Authors:  F A Reichle; K P Rankin; R R Tyson; A J Finestone; C Shuman
Journal:  Surgery       Date:  1979-01       Impact factor: 3.982

4.  In situ vein bypasses to distal tibial and limited outflow tracts for limb salvage.

Authors:  J D Corson; A M Karmody; D M Shah; V Naraynsingh; H L Young; R P Leather
Journal:  Surgery       Date:  1984-10       Impact factor: 3.982

5.  Infrapopliteal arterial bypass for limb salvage: increased patency and utilization of the saphenous vein used "in situ".

Authors:  R P Leather; D M Shan; A M Karmody
Journal:  Surgery       Date:  1981-12       Impact factor: 3.982

6.  Observations on the use of thrombolytic agents for thrombotic occlusion of infrainguinal vein grafts.

Authors:  M Belkin; M C Donaldson; A D Whittemore; J F Polak; C J Grassi; D P Harrington; J A Mannick
Journal:  J Vasc Surg       Date:  1990-02       Impact factor: 4.268

7.  Expanded polytetrafluoroethylene grafts in reconstructive arterial surgery. Preliminary report of the first 110 consecutive cases for limb salvage.

Authors:  F J Veith; C M Moss; S C Fell; B A Rhodes; E Somberg; P Weiss; S J Boley; H Haimovici
Journal:  JAMA       Date:  1978-10-20       Impact factor: 56.272

8.  Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified?

Authors:  W J Quiñones-Baldrich; R W Busuttil; J D Baker; C L Vescera; S S Ahn; H I Machleder; W S Moore
Journal:  J Vasc Surg       Date:  1988-09       Impact factor: 4.268

9.  Seven-year experience with polytetrafluoroethylene as above-knee femoropopliteal bypass graft. Is is worthwhile to preserve the autologous saphenous vein?

Authors:  A V Sterpetti; R D Schultz; R J Feldhaus; D J Peetz
Journal:  J Vasc Surg       Date:  1985-11       Impact factor: 4.268

10.  What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction?

Authors:  A D Whittemore; K C Kent; M C Donaldson; N P Couch; J A Mannick
Journal:  J Vasc Surg       Date:  1989-09       Impact factor: 4.268

View more
  1 in total

1.  In vivo modulation of Nogo-B attenuates neointima formation.

Authors:  Angelika B Kritz; Jun Yu; Paulette L Wright; Song Wan; Sarah J George; Crawford Halliday; Ning Kang; William C Sessa; Andrew H Baker
Journal:  Mol Ther       Date:  2008-09-09       Impact factor: 11.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.